AN UNBIASED VIEW OF LINK ALTERNATIF MBL77

Not all patients with CLL have to have therapy. Irrespective of all latest advances, the iwCLL continue to suggests watchful observation for patients with asymptomatic disorder.86 This recommendation is based on a minimum of two randomized trials comparing observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab